Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Biopharma Cred. (BPCR) Share Price

Price $0.896 on 05-11-2025 at 06:00:02
Change $0.00 0%
Buy $0.00
Sell $0.00
Last Trade: Sell 775.00 at $0.89607
Day's Volume: 0
Last Close: $0.896
Open: $0.00
ISIN: GB00BDGKMY29
Day's Range $0.00 - $0.00
52wk Range: $0.80 - $0.94
Market Capitalisation: $1.01b
VWAP: $0.00
Shares in Issue: 1.13b

Biopharma Cred. (BPCR) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 775 $0.89607 SI Trade
Suspected SELL Trade
16:47:03 - 04-Nov-25
Sell* 52,290 $0.896 Uncrossing Trade
16:35:07 - 04-Nov-25
Unknown* 14,374 $0.902677 Ordinary
Currency Conversion
15:44:57 - 04-Nov-25
Buy* 4,800 $0.896 Automatic Execution
15:39:15 - 04-Nov-25
Buy* 3,648 $0.896 Automatic Execution
15:39:01 - 04-Nov-25
Sell* 18,012 $0.896 Automatic Execution
15:39:01 - 04-Nov-25
Buy* 5,702 $0.90139 Ordinary
15:33:37 - 04-Nov-25
Unknown* 10,600 $0.90 OTC Trade
15:29:46 - 04-Nov-25
Buy* 240 $0.902 SI Trade
15:26:33 - 04-Nov-25
Buy* 2,237 $0.90 SI Trade
15:08:46 - 04-Nov-25
See more Biopharma Cred. trades

Biopharma Cred. (BPCR) Share Price History

Time period:
to
Date Open High Low Close Volume
5th Nov 2025 (Wed) 0.896 0.896 0.896 0.896 0
4th Nov 2025 (Tue) 0.894 0.908 0.894 0.896 503,445
3rd Nov 2025 (Mon) 0.914 0.914 0.894 0.896 971,972
31st Oct 2025 (Fri) 0.906 0.908 0.898 0.898 1,338,925
30th Oct 2025 (Thu) 0.91 0.91 0.894 0.894 748,815
29th Oct 2025 (Wed) 0.908 0.91 0.892 0.902 754,117
28th Oct 2025 (Tue) 0.918 0.918 0.904 0.908 855,803
27th Oct 2025 (Mon) 0.928 0.928 0.912 0.916 426,749
24th Oct 2025 (Fri) 0.928 0.928 0.914 0.92 574,509
23rd Oct 2025 (Thu) 0.92 0.92 0.912 0.92 1,022,405
22nd Oct 2025 (Wed) 0.918 0.926 0.914 0.92 532,864
21st Oct 2025 (Tue) 0.922 0.926 0.912 0.914 329,644
20th Oct 2025 (Mon) 0.93 0.93 0.914 0.918 1,044,133
17th Oct 2025 (Fri) 0.92 0.922 0.916 0.916 637,270
16th Oct 2025 (Thu) 0.934 0.934 0.92 0.926 497,306
15th Oct 2025 (Wed) 0.936 0.936 0.92 0.928 1,463,399
14th Oct 2025 (Tue) 0.922 0.94 0.918 0.93 4,074,501
13th Oct 2025 (Mon) 0.924 0.928 0.918 0.922 1,067,041
10th Oct 2025 (Fri) 0.92 0.928 0.91 0.92 1,340,140
9th Oct 2025 (Thu) 0.918 0.926 0.898 0.926 1,411,658
8th Oct 2025 (Wed) 0.916 0.916 0.90 0.90 1,107,540
7th Oct 2025 (Tue) 0.92 0.92 0.902 0.908 672,579
6th Oct 2025 (Mon) 0.916 0.92 0.91 0.92 381,337
See more Biopharma Cred. price history

Biopharma Cred. (BPCR) Regulatory News

Date Source Headline
4th Nov 2025 3:29 pm RNS Director/PDMR Shareholding
24th Oct 2025 4:00 pm RNS Net Asset Value(s) and Monthly Factsheet
21st Oct 2025 7:00 am RNS UPDATES ON INVESTMENT PORTFOLIO
7th Oct 2025 7:00 am RNS NEW INVESTMENT OF US$30 MILLION
23rd Sep 2025 4:00 pm RNS Net Asset Value(s) and Monthly Factsheet
22nd Sep 2025 7:00 am RNS Half-year Report
18th Sep 2025 5:15 pm RNS Dividend Declaration
3rd Sep 2025 12:21 pm RNS NEW INVESTMENT OF UP TO US$62.5 MILLION
1st Sep 2025 2:26 pm RNS Total Voting Rights
26th Aug 2025 7:00 am RNS Notice of Half Year Results
See more Biopharma Cred. regulatory news

Biopharma Cred. (BPCR) Share News

UK dividends calendar - next 7 days

24th Oct 2025 11:25

Read More

IN BRIEF: Biopharma Credit increases loan commitment to Valneva

7th Oct 2025 11:22

BioPharma Credit PLC - London-based closed-ended investment company focused on life sciences industry - Provides a senior secured loan to Valneva Austria GmbH, a subsidiary of Valneva SE. Initial tranche is expected to be funded in the coming weeks, with BioPharma investing USD30 million and BioPharma Credit Investments V (Master) LP investing an additional USD185 million in parallel, and BioPharma acting as collateral agent. "Further tranches of up to USD285 million for potential business development are subject to mutual agreement by the parties with loan allocations to be determined at such time," BioPharma adds. The loan to Valneva will mature in October 2030 and bear an interest of 9.00% per year. Read More

BioPharma Credit expects pipeline growth as net asset value ticks up

22nd Sep 2025 09:37

(Alliance News) - BioPharma Credit PLC on Monday said net asset value increased, while the net income for the first half of the year substantially covered its annual dividend target. Read More

UK earnings, trading statements calendar - next 7 days

15th Sep 2025 15:29

Read More

Burberry, recently debuted Metlen Energy & Metals to join FTSE 100

3rd Sep 2025 19:40

(Alliance News) - Burberry Group PLC and Metlen Energy & Metals PLC have been promoted to the FTSE 100 in its latest quarterly shuffle, with Taylor Wimpey PLC and Unite Group PLC relegated from the benchmark index. Read More

See more Biopharma Cred. news
FTSE 100 Latest
Value9,714.96
Change13.59

Login to your account

Forgot Password?

Not Registered